The goal of this proposal is to develop and evaluate hyperpolarized helium-3 diffusion magnetic resonance imaging (He-3 dMRI) and low dose quantitative computed tomography (LD-QCT) indexes of emphysema as noninvasive biomarkers for the presence, severity, and progression of emphysema. Emphysema is a pathologic abnormality of the lungs defined by enlargement of terminal airspaces and destruction of airspace walls, and is commonly present in the millions of patients with chronic obstructive pulmonary disease. Increased knowledge regarding the role of inflammatory mechanisms and proteinases in the pathogenesis of COPD is leading to searches for newer anti-inflammatory strategies and enzyme inhibitors. Though in the early stages of development, some of these new approaches may eventually provide therapy that alters the course of the disease. Accurate biomarkers of emphysema would allow for early diagnosis, intervention, and evaluation of new therapies. Though spirometry is used to diagnose COPD, it is a relatively inaccurate means of assessing for emphysema. Conventional CT is a highly accurate way to assess the severity of emphysema, which can be quantified by the decrease in x-ray attenuation of the lungs that results from airspace enlargement and alveolar destruction. However, CT is performed using relatively high doses of ionizing radiation, which limits its acceptability as a screening and follow-up test, particularly in early or mild disease. In recent years, other noninvasive imaging tests for emphysema have been designed that require no or greatly reduced ionizing radiation. One new test, He-3 dMRI, uses a specially constructed MRI pulse sequence to measure the degree to which diffusivity of inhaled hyperpolarized He-3 gas is restricted by alveolar walls. This measurement, the apparent diffusion coefficient (ADC), is increased (gas diffusion is less restricted) when alveolar spaces are enlarged in emphysema. Another test, low dose CT scanning, allows depiction of substantial lung detail at less than 20 percent of the radiation dose of conventional CT, but has not been developed for quantitation of emphysema. Though promising, the optimal technique and validity of both He-3 dMRI and LD-QCT have yet to be established. We hypothesize that 1) Optimizing He-3 dMRI and LD-QCT techniques will allow sensitive and accurate assessment of emphysema, compared to lung morphometry, 2) The optimized He-3 dMRI and LD-QCT techniques will provide valid biomarkers of emphysema that can be applied to other populations, and 3) He-3 dMRI and LD-QCT will allow identification of emphysema progression over time. We will study three separate groups of subjects. In the first group, we will determine which scanning and analysis parameters provide ADC and LD-QCT biomarkers that most accurately quantify the amount of emphysema present pathologically in lobectomy specimens (Aim I). We will then use the optimized scanning and analysis techniques to validate these measurements in a different group, compared to the amount of emphysema present in lobectomy specimens (Aim II). In a third group of subjects, we will determine ADC and LD-QCT lung attenuation measurements at serial time points to assess for emphysema progression (Aim III).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL072369-01
Application #
6571721
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Program Officer
Croxton, Thomas
Project Start
2002-09-23
Project End
2006-07-31
Budget Start
2002-09-23
Budget End
2003-07-31
Support Year
1
Fiscal Year
2002
Total Cost
$382,500
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Yablonskiy, Dmitriy A; Sukstanskii, Alexander L; Quirk, James D et al. (2014) Probing lung microstructure with hyperpolarized noble gas diffusion MRI: theoretical models and experimental results. Magn Reson Med 71:486-505
Bartel, Seth T; Bierhals, Andrew J; Pilgram, Thomas K et al. (2011) Equating quantitative emphysema measurements on different CT image reconstructions. Med Phys 38:4894-902
Pilgram, Thomas K; Quirk, James D; Bierhals, Andrew J et al. (2010) Accuracy of emphysema quantification performed with reduced numbers of CT sections. AJR Am J Roentgenol 194:585-91
Gierada, David S; Bierhals, Andrew J; Choong, Cliff K et al. (2010) Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol 17:146-56
Gierada, David S; Woods, Jason C; Jacob, Richard E et al. (2010) Emphysema quantification in inflation-fixed lungs using low-dose computed tomography and 3He magnetic resonance imaging. J Comput Assist Tomogr 34:773-9
Gierada, David S; Woods, Jason C; Bierhals, Andrew J et al. (2009) Effects of diffusion time on short-range hyperpolarized (3)He diffusivity measurements in emphysema. J Magn Reson Imaging 30:801-8
Yablonskiy, Dmitriy A; Sukstanskii, Alexander L; Woods, Jason C et al. (2009) Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol (1985) 107:1258-65
Bartel, Seth-Emil T; Haywood, Susan E; Woods, Jason C et al. (2008) Role of collateral paths in long-range diffusion in lungs. J Appl Physiol 104:1495-503
Conradi, Mark S; Yablonskiy, Dmitriy A; Woods, Jason C et al. (2008) The role of collateral paths in long-range diffusion of 3He in lungs. Acad Radiol 15:675-82
Lutey, Barbara A; Lefrak, Stephen S; Woods, Jason C et al. (2008) Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. Radiology 248:655-61

Showing the most recent 10 out of 13 publications